Related Experiment Video
Updated: Jun 9, 2025

13:53
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
4.9K
Navigating vaccine procurement and financing challenges in Cameroon: Insights and recommendations from a
Yauba Saidu1, Budzi Michael Ngenge2, Sangwe Clovis Nchinjoh2
1Clinton Health Access Initiative Inc., Yaounde, PO Box 2664, Cameroon; Institute for Global Health, University of Siena, 53100, Siena, Italy.
Public Health
|October 28, 2024
Summary
Cameroon
Area of Science:
- Public Health
- Health Systems Strengthening
- Vaccine Procurement and Financing
Background:
- Vaccine stockouts are a critical challenge to immunization coverage.
- Issues include funding delays, poor forecasting, and inefficient procurement.
- Understanding these barriers is vital for improving vaccine access, especially for zero-dose children.
Purpose of the Study:
- To comprehensively assess the vaccine procurement and financing landscape in Cameroon.
- To identify barriers contributing to vaccine stockouts from 2015 to 2020.
Main Methods:
- Descriptive cross-sectional study utilizing a mixed-methods approach.
- Included a desk review of documents and in-depth interviews with key stakeholders.
- Data analyzed using Microsoft Excel 365 and Dedoose software.
Main Results:
- Vaccine procurement processes were complex with protracted timelines and multiple stakeholders.
- The Expanded Program on Immunization (EPI) faced a USD 4 million funding deficit (2016-2019).
- This resulted in delayed vaccine acquisition and 41 months of stockouts for at least one antigen.
Conclusions:
- Procurement and financing challenges significantly impact vaccine availability.
- Recommendations include optimizing resource allocation and streamlining processes.
- Establishing a joint procurement working group could reduce stockouts and improve vaccine coverage.
Related Concept Videos
Vaccinations
44.1K
Overview
44.1K
International Nursing Organizations II
971
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
971
Cross-reactivity
31.0K
Overview
31.0K
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342

